07:00 , Jul 14, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Homeobox C10 (HOXC10); cyclin dependent kinase 7 (CDK7)

Cancer INDICATION: Breast cancer Patient sample and cell culture studies suggest CDK7 inhibitors could help treat HOXC10-expressing, chemotherapy-resistant breast cancer. In breast cancer patients receiving chemotherapy, levels of HOXC10 mRNA were 10 times higher in primary tumors...
07:00 , Apr 24, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Breast cancer Homeobox C10 (HOXC10) In vitro and mouse studies suggest decreasing HOXC10 methylation could help treat...